Home › Funds › SATURNA CAPITAL CORP › AZN

SATURNA CAPITAL CORP position in AZN

ASTRAZENECA PLC · Health Care

SATURNA CAPITAL CORP reported holding 911,933 shares of AZN (ASTRAZENECA PLC) in its Q2 2026 13F filing — a position valued at US$155.1M, representing 1.89% of its reported portfolio and ranking #17 among its reported holdings. SATURNA CAPITAL CORP has disclosed AZN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)911.93K sh
Reported value held$155.07M
Portfolio Weight1.89%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SATURNA CAPITAL CORP's AZN position evolved

SATURNA CAPITAL CORP first disclosed a stake in AZN in Q3 2023 at 1,074,573 shares (US$72.8M). The position peaked in Q1 2026 at 821,571 shares, worth US$162.0M. Across 12 filings, SATURNA CAPITAL CORP increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 911,933 shares valued at US$155.1M — an increase of 90,362 shares quarter over quarter.. Notable position changes include a 31% increase in Q1 2024 (shares rose 15% over the following quarter), a 50% trim in Q1 2026 (shares fell 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.07M $72.77M New
Q4 2023 1.27M $85.77M Add
Q1 2024 1.67M $113.08M Add
Q2 2024 1.67M $130.42M Hold
Q3 2024 1.67M $130.49M Hold
Q4 2024 1.64M $107.28M Reduce
Q1 2025 1.64M $120.25M Hold
Q2 2025 1.63M $114.16M Hold
Q3 2025 1.63M $125.44M Hold
Q4 2025 1.64M $150.32M Hold
Q1 2026 821.57K $161.97M Reduce
Q2 2026 911.93K $155.07M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AZN and 13F data

AZN (ASTRAZENECA PLC) is a Health Care company. 71 other funds we track also report a position in AZN — the largest reported positions include Evelyn Partners Group Ltd (US$41.52B), Banque Cantonale Vaudoise (US$11.31B), INVESTOR AB (US$9.78B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AZN

All AZN fund holders →

FAQ

How long has SATURNA CAPITAL CORP held AZN?

SATURNA CAPITAL CORP has disclosed AZN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is SATURNA CAPITAL CORP's current position in AZN?

As of Q2 2026, SATURNA CAPITAL CORP holds 911.93K shares of AZN (ASTRAZENECA PLC), valued at $155.07M, representing 1.89% of its reported portfolio and ranking #17.

Has SATURNA CAPITAL CORP been buying or selling AZN?

In the latest 13F filing (Q2 2026), SATURNA CAPITAL CORP increased its position in AZN. The position peaked in Q1 2026 at 821.57K shares.

Which other funds hold AZN?

Other major institutional holders of AZN include Evelyn Partners Group Ltd, Banque Cantonale Vaudoise, INVESTOR AB, among 71 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.